Integrated Pharma Magazine

New Drug Applications • Pharma Industry News

F.D.A. Approves a New Antipsychotic Drug

2 weeks ago

by David Miller

946 Views

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment X

[mwai_chat window="true" fullscreen="true"]